Distribution of pathogenicity islands OI-122, OI-43/48, and OI-57 and a high-pathogenicity island in Shiga toxin-producing Escherichia coli

Applied and Environmental Microbiology

Volumn 79, Issue 11, 2013, Pages 3406-3412

  Ju, Wenting ^a   Shen, Jinling ^a,b   Toro, Magaly ^a   Zhao, Shaohua ^c   Menga, Jianghong ^a  

^a UNIVERSITY OF MARYLAND   (United States)

^b NORTHWEST A F UNIVERSITY   (China)

^c CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FRAGMENT LENGTHS; PATHOGENIC E. COLI; PATHOGENIC MECHANISMS; PHYLOGENETIC TREES; SHIGA TOXIN-PRODUCING ESCHERICHIA COLI; STX GENES; VIRULENCE GENE;

GENES;

ESCHERICHIA COLI;

BIOASSAY; DISEASE PREVALENCE; DISEASE SEVERITY; GENE; MICROBIAL COMMUNITY; PATHOGENICITY; POLYMORPHISM; VIRULENCE;

ARTICLE; GENETIC MARKER; GENETICS; GENOMIC ISLAND; PATHOGENICITY; PHYLOGENY; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEROTYPING; SHIGA TOXIN PRODUCING ESCHERICHIA COLI; SPECIES DIFFERENCE;

GENETIC MARKERS; GENOMIC ISLANDS; PHYLOGENY; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; SEROTYPING; SHIGA-TOXIGENIC ESCHERICHIA COLI; SPECIES SPECIFICITY;

EID: 84877150009     PISSN: 00992240     EISSN: 10985336     Source Type: Journal    
DOI: 10.1128/AEM.03661-12     Document Type: Article

References (44)

1. Bettelheim KA. 2007. The non-O157 Shiga-toxigenic (verocytotoxigenic) Escherichia coli: under-rated pathogens. Crit. Rev. Microbiol. 33:67- 87.
2. Blanco M, Blanco JE, Mora A, Dahbi G, Alonso MP, Gonzalez EA, Bernardez MI, Blanco J. 2004. Serotypes, virulence genes, and intimin types of Shiga toxin (verotoxin)-producing Escherichia coli isolates from cattle in Spain and identification of a new intimin variant gene (eae-xi). J. Clin. Microbiol. 42:645- 651.
3. Scallan E, Hoekstra RM, Angulo FJ, Tauxe RV, Widdowson MA, Roy SL, Jones JL, Griffin PM. 2011. Foodborne illness acquired in the United States: major pathogens. Emerg. Infect. Dis. 17:7-15.
4. Coombes BK, Gilmour MW, Goodman CD. 2011. The evolution of virulence in non-O157 Shiga toxin-producing Escherichia coli. Front. Microbiol. 2:90.
5. Karmali MA, Mascarenhas M, Shen S, Ziebell K, Johnson S, Reid-Smith R, Isaac-Renton J, Clark C, Rahn K, Kaper JB. 2003. Association of genomic O island 122 of Escherichia coli EDL 933 with verocytotoxinproducing Escherichia coli seropathotypes that are linked to epidemic and/or serious disease. J. Clin. Microbiol. 41:4930-4940.
6. Gal-Mor O, Finlay BB. 2006. Pathogenicity islands: a molecular toolbox for bacterial virulence. Cell. Microbiol. 8:1707-1719.
7. Wickham ME, Lupp C, Mascarenhas M, Vazquez A, Coombes BK, Brown NF, Coburn BA, Deng W, Puente JL, Karmali MA, Finlay BB. 2006. Bacterial genetic determinants of non-O157 STEC outbreaks and hemolytic-uremic syndrome after infection. J. Infect. Dis. 194:819-827.
8. Perna NT, Plunkett G, III, Burland V, Mau B, Glasner JD, Rose DJ, Mayhew GF, Evans PS, Gregor J, Kirkpatrick HA, Posfai G, Hackett J, Klink S, Boutin A, Shao Y, Miller L, Grotbeck EJ, Davis NW, Lim A, Dimalanta ET, Potamousis KD, Apodaca J, Anantharaman TS, Lin J, Yen G, Schwartz DC, Welch RA, Blattner FR. 2001. Genome sequence of enterohaemorrhagic Escherichia coli O157:H7. Nature 409:529 -533.
9. Konczy P, Ziebell K, Mascarenhas M, Choi A, Michaud C, Kropinski AM, Whittam TS, Wickham M, Finlay B, Karmali MA. 2008. Genomic O island 122, locus for enterocyte effacement, and the evolution of virulent verocytotoxin-producing Escherichia coli. J. Bacteriol. 190:5832- 5840.
10. Abu-Median AB, van Diemen PM, Dziva F, Vlisidou I, Wallis TS, Stevens MP. 2006. Functional analysis of lymphostatin homologues in enterohaemorrhagic Escherichia coli. FEMS Microbiol. Lett. 258:43- 49.
11. Taylor DE, Rooker M, Keelan M, Ng LK, Martin I, Perna NT, Burland NT, Blattner FR. 2002. Genomic variability ofOislands encoding tellurite resistance in enterohemorrhagic Escherichia coli O157:H7 isolates. J. Bacteriol. 184:4690-4698.
12. Yin X, Wheatcroft R, Chambers JR, Liu B, Zhu J, Gyles CL. 2009. Contributions of O island 48 to adherence of enterohemorrhagic Escherichia coli O157:H7 to epithelial cells in vitro and in ligated pig ileal loops. Appl. Environ. Microbiol. 75:5779 -5786.
13. Coombes BK, Wickham ME, Mascarenhas M, Gruenheid S, Finlay BB, Karmali MA. 2008. Molecular analysis as an aid to assess the public health risk of non-O157 Shiga toxin-producing Escherichia coli strains. Appl. Environ. Microbiol. 74:2153-2160.
14. Imamovic L, Tozzoli R, Michelacci V, Minelli F, Marziano ML, Caprioli A, Morabito S. 2010. OI-57, a genomic island of Escherichia coli O157, is present in other seropathotypes of Shiga toxin-producing E. coli associated with severe human disease. Infect. Immun. 78:4697- 4704.
15. Wu B, Skarina T, Yee A, Jobin MC, Dileo R, Semesi A, Fares C, Lemak A, Coombes BK, Arrowsmith CH, Singer AU, Savchenko A. 2010. NleG type 3 effectors from enterohaemorrhagic Escherichia coli are U-box E3 ubiquitin ligases. PLoS Pathog. 6:e1000960. doi:10.1371/journal.ppat .1000960.
16. Schubert S, Darlu P, Clermont O, Wieser A, Magistro G, Hoffmann C, Weinert K, Tenaillon O, Matic I, Denamur E. 2009. Role of intraspecies recombination in the spread of pathogenicity islands within the Escherichia coli species. PLoS Pathog. 5:e1000257. doi:10.1371/journal.ppat .1000257.
17. Benedek O, Schubert S. 2007. Mobility of the Yersinia high-pathogenicity island (HPI): transfer mechanisms of pathogenicity islands (PAIs) revisited (a review). Acta Microbiol. Immunol. Hung. 54:89 -105.
18. Toma C, Martínez Espinosa E, Song T, Miliwebsky E, Chinen I, Iyoda S, Iwanaga M, Rivas M. 2004. Distribution of putative adhesins in different seropathotypes of Shiga toxin-producing Escherichia coli. J. Clin. Microbiol. 42:4937- 4946.
19. Beutin L, Miko A, Krause G, Pries K, Haby S, Steege K, Albrecht N. 2007. Identification of human-pathogenic strains of Shiga toxinproducing Escherichia coli from food by a combination of serotyping and molecular typing of Shiga toxin genes. Appl. Environ. Microbiol. 73: 4769-4775.
20. Tramuta C, Robino P, Oswald E, Nebbia P. 2008. Identification of intimin alleles in pathogenic Escherichia coli by PCR-restriction fragment length polymorphism analysis. Vet. Res. Commun. 32:1-5.
21. Zheng J, Cui S, Teel LD, Zhao S, Singh R, O'Brien AD, Meng J. 2008. Identification and characterization of Shiga toxin type 2 variants in Escherichia coli isolates from animals, food, and humans. Appl. Environ. Microbiol. 74:5645-5652.
22. Xia X, Meng J, McDermott PF, Ayers S, Blickenstaff K, Tran TT, Abbott J, Zheng J, Zhao S. 2010. Presence and characterization of Shiga toxin-producing Escherichia coli and other potentially diarrheagenic E. coli strains in retail meats. Appl. Environ. Microbiol. 76:1709 -1717.
23. Ju W, Shen J, Li Y, Toro MA, Zhao S, Ayers S, Najjar MB, Meng J. 2012. Non-O157 Shiga toxin-producing Escherichia coli in retail ground beef and pork in the Washington D.C. area. Food Microbiol. 32:371-377.
24. Nakano M, Iida T, Ohnishi M, Kurokawa K, Takahashi A, Tsukamoto T, Yasunaga T, Hayashi T, Honda T. 2001. Association of the urease gene with enterohemorrhagic Escherichia coli strains irrespective of their serogroups. J. Clin. Microbiol. 39:4541- 4543.
25. Karch H, Schubert S, Zhang D, Zhang W, Schmidt H, Olschläger T, Hacker J. 1999. A genomic island, termed high-pathogenicity island, is present in certain non-O157 Shiga toxin-producing Escherichia coli clonal lineages. Infect. Immun. 67:5994-6001.
26. Tamura K, Peterson D, Peterson N, Stecher G, Nei M, Kumar S. 2011. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum-parsimony methods. Mol. Biol. Evol. 28:2731-2739.
27. Nicholls L, Grant TH, Robins-Browne RM. 2000. Identification of a novel genetic locus that is required for in vitro adhesion of a clinical isolate of enterohaemorrhagic Escherichia coli to epithelial cells. Mol. Microbiol. 35:275-288.
28. Klapproth JM, Scaletsky IC, McNamara BP, Lai LC, Malstrom C, James SP, Donnenberg MS. 2000. A large toxin from pathogenic Escherichia coli strains that inhibits lymphocyte activation. Infect. Immun. 68:2148 -2155.
29. Klapproth JM, Sasaki M, Sherman M, Babbin B, Donnenberg MS, Fernandes PJ, Scaletsky IC, Kalman D, Nusrat A, Williams IR. 2005. Citrobacter rodentium lifA/efa1 is essential for colonic colonization and crypt cell hyperplasia in vivo. Infect. Immun. 73:3196.
30. Kelly M, Hart E, Mundy R, Marches O, Wiles S, Badea L, Luck S, Tauschek M, Frankel G, Robins-Browne RM, Hartland EL. 2006. Essential role of the type III secretion system effector NleB in colonization of mice by Citrobacter rodentium. Infect. Immun. 74:2328 -2337.
31. Steyert SR, Rasko DA, Kaper JB. 2011. Functional and phylogenetic analysis of ureD in Shiga toxin-producing Escherichia coli. J. Bacteriol. 193:875- 886.
32. Steyert SR, Kaper JB. 2012. Contribution of urease to colonization by Shiga toxin-producing Escherichia coli. Infect. Immun. 80:2589 -2600.
33. Friedrich AW, Lukas R, Mellmann A, Kock R, Zhang W, Mathys W, Bielaszewska M, Karch H. 2006. Urease genes in non-O157 Shiga toxinproducing Escherichia coli: mostly silent but valuable markers for pathogenicity. Clin. Microbiol. Infect. 12:483- 486.
34. Schmidt H, Zhang WL, Hemmrich U, Jelacic S, Brunder W, Tarr PI, Dobrindt U, Hacker J, Karch H. 2001. Identification and characterization of a novel genomic island integrated at selC in locus of enterocyte effacement-negative, Shiga toxin-producing Escherichia coli. Infect. Immun. 69:6863- 6873.
35. Newton HJ, Sloan J, Bulach DM, Seemann T, Allison CC, Tauschek M, Robins-Browne RM, Paton JC, Whittam TS, Paton AW, Hartland EL. 2009. Shiga toxin-producing Escherichia coli strains negative for locus of enterocyte effacement. Emerg. Infect. Dis. 15:372-380.
36. Shen S, Mascarenhas M, Rahn K, Kaper JB, Karmali MA. 2004. Evidence for a hybrid genomic island in verocytotoxin-producing Escherichia coli CL3 (serotype O113:H21) containing segments of EDL933 (serotype O157:H7) O islands 122 and 48. Infect. Immun. 72:1496 -1503.
37. Girardeau JP, Bertin Y, Martin C. 2009. Genomic analysis of the PAI ICL3 locus in pathogenic LEE-negative Shiga toxin-producing Escherichia coli and Citrobacter rodentium. Microbiology 155:1016 -1027.
38. Luck SN, Badea L, Bennett-Wood V, Robins-Browne R, Hartland EL. 2006. Contribution of FliC to epithelial cell invasion by enterohemorrhagic Escherichia coli O113:H21. Infect. Immun. 74:6999 -7004.
39. Steyert SR, Sahl JW, Fraser CM, Teel LD, Scheutz F, Rasko DA. 2012. Comparative genomics and stx phage characterization of LEE-negative Shiga toxin-producing Escherichia coli. Front. Cell. Infect. Microbiol. 2:133.
40. Bugarel M, Beutin L, Fach P. 2010. Low-density macroarray targeting non-locus of enterocyte effacement effectors (nle genes) and major virulence factors of Shiga toxin-producing Escherichia coli (STEC): a new approach for molecular risk assessment of STEC isolates. Appl. Environ. Microbiol. 76:203-211.
41. Bugarel M, Beutin L, Martin A, Gill A, Fach P. 2010. Micro-array for the identification of Shiga toxin-producing Escherichia coli (STEC) seropathotypes associated with hemorrhagic colitis and hemolytic uremic syndrome in humans. Int. J. Food Microbiol. 142:318 -329.
42. Bugarel M, Martin A, Fach P, Beutin L. 2011. Virulence gene profiling of enterohemorrhagic (EHEC) and enteropathogenic (EPEC) Escherichia coli strains: a basis for molecular risk assessment of typical and atypical EPEC strains. BMC Microbiol. 11:142. doi:10.1186/1471-2180-11-142.
43. Bosilevac JM, Koohmaraie M. 2011. Prevalence and characterization of non-O157 Shiga toxin-producing Escherichia coli isolates from commercial ground beef in the United States. Appl. Environ. Microbiol. 77:2103- 2112.
44. Mundy R, Jenkins C, Yu J, Smith H, Frankel G. 2004. Distribution of espI among clinical enterohaemorrhagic and enteropathogenic Escherichia coli isolates. J. Med. Microbiol. 53:1145-1149.